Logotype for Transense Technologies plc

Transense Technologies (TRT) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Transense Technologies plc

H1 2025 earnings summary

10 Dec, 2025

Executive summary

  • Revenue grew 36% year-over-year to £2.46m for the six months ended 31 December 2024, with strong performance across all business segments and strategic investments in team and production capabilities.

  • Two main operating businesses: SAWsense (advanced sensor solutions) and Translogik (smart tire inspection tools), both targeting high-growth, blue-chip markets.

  • Ongoing royalty income from the 2020 iTrack sale to Bridgestone provides financial stability, with about half of the 10-year royalty collected to date and a fivefold increase in installations since 2020.

  • Expanded headcount from 18 to 31 to support future growth and capacity.

  • Trading remains in line with market expectations, with the company positioned for further expansion.

Financial highlights

  • Total revenue up 36% year-over-year to £2.46m; gross margin improved to 90% (up from 88% prior year); gross profit up 40%.

  • Operating expenses rose 73% as headcount grew, supporting future growth; operating costs increased to £1.66m.

  • Adjusted operating profit for H1 FY25 was £0.55m, down 11% year-over-year due to higher operating expenses; profit before tax was £0.55m, down 13%.

  • EPS decreased 16% to 3.61p.

  • Cash at period end was £1.19m, rising to £1.87m post-period after royalty receipt.

Outlook and guidance

  • Expect near doubling of H1 revenue in H2 for both SAWsense and Translogik, based on strong pipeline conversion and new business wins.

  • Directors expect to meet full-year market expectations for FY25, with accelerating revenue conversion in SAWsense and iTrack.

  • Cost base is now set to support anticipated growth, with limited further increases expected.

  • Research forecasts for FY2027: revenues over £7 million and PBT at £2 million.

  • Significant capital expenditure planned (£2–2.5m over 12–18 months), funded by cash and asset-backed loans.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more